Barbut F, Soukouna S, Lalande V, Garcia M-L, Neyme D, de Gramont A, Petit J-C
Unité d'hygiène et de lutte contre les infections nosocomiales, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Pathol Biol (Paris). 2004 Dec;52(10):566-74. doi: 10.1016/j.patbio.2004.07.020.
Totally implantable venous access ports (TIVAP) are valuable medical devices for long-term intravenous treatment such as parenteral nutrition, cancer chemotherapy or antiviral therapy. Implantation and use of these devices are each associated with infectious or mechanical complications.
To determine the frequency of complications and to analyze bacterial contamination of different parts of TIVAP (tip, septum, internal lumen of the port).
Clinical charts of patients, which TIVAP was removed between April 20th to December 31st 2003, were retrospectively reviewed. Infectious complications (local and septicemic) and non-infectious complications (i.e. obstruction, thrombosis, drug extravasation...) were defined using clinical and/or microbiological criteria. Quantitative culture from different parts of the TIVAP was performed.
One hundred and ten patients (age 57 +/- 14-years-old, 94.3% cancers) were included, corresponding to 57,018 catheter-days: 39.1% had one or more non-infectious complications (density incidence: 0.86 for 1000 catheter-days). Among the 49 complications, obstruction, thrombosis, extravasations and malposition accounted for 30.6%, 30.6% 4.1% and 6% of cases. Twenty-one patients (19.1%) had an infectious complication: 11 were local and 14 were systemic (density incidence 0.43 for 1000 catheter-days). Bacteria responsible for TIVAP-associated bacteraemia were coagulase negative staphylococci (N = 2), Staphylococcus aureus susceptible to methicilline (N = 3), micrococci (N = 1), corynebacteria (N = 1) or Gram-negative bacilli (N = 8). Comparison of quantitative culture of the different parts of TIVAP with a threshold at 10(3) CFU/ml showed that culture of tip, septum and port has a sensitivity of 47.6% 57.1% and 61.9 %, respectively and a specificity of 100% 92.1% and 92.1%, respectively for the diagnosis of TIVAP infection.
Complications associated to TIVAP are frequent but incidence that we have reported is comparable with previous studies. Analysis of internal lumen of the port is the most sensitive method for the diagnosis of TIVAP-associated infections.
完全植入式静脉通路端口(TIVAP)是用于长期静脉治疗的重要医疗设备,如肠外营养、癌症化疗或抗病毒治疗。这些设备的植入和使用均与感染性或机械性并发症相关。
确定并发症的发生率,并分析TIVAP不同部位(尖端、隔膜、端口内腔)的细菌污染情况。
回顾性分析2003年4月20日至12月31日期间移除TIVAP的患者临床病历。根据临床和/或微生物学标准定义感染性并发症(局部和败血症性)和非感染性并发症(即阻塞、血栓形成、药物外渗等)。对TIVAP的不同部位进行定量培养。
纳入110例患者(年龄57±14岁,94.3%为癌症患者),对应57018个导管日:39.1%的患者发生一种或多种非感染性并发症(密度发生率:每1000导管日0.86)。在49例并发症中,阻塞、血栓形成、外渗和位置异常分别占病例的30.6%、30.6%、4.1%和6%。21例患者(19.1%)发生感染性并发症:11例为局部感染,14例为全身感染(密度发生率:每1000导管日0.43)。导致TIVAP相关菌血症的细菌为凝固酶阴性葡萄球菌(N = 2)、对甲氧西林敏感的金黄色葡萄球菌(N = 3)、微球菌(N = 1)、棒状杆菌(N = 1)或革兰氏阴性杆菌(N = 8)。将TIVAP不同部位的定量培养结果与阈值10³CFU/ml进行比较,结果显示,对于TIVAP感染的诊断,尖端、隔膜和端口培养的敏感性分别为47.6%、57.1%和61.9%,特异性分别为100%、92.1%和92.1%。
TIVAP相关并发症很常见,但我们报告的发生率与先前研究相当。端口内腔分析是诊断TIVAP相关感染最敏感的方法。